Literature DB >> 23604870

Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: A review.

Q W Fan1, I Iosbe, H Asou, K Yanagisawa, M Michikawa.   

Abstract

The importance of apolipoprotein E (apoE) in the central nervous system (CNS) became increasingly clear since the descovery that apoE ε4 allele is a major risk factor for Alzheimer's disease. ApoE is one of the major apolipoproteins that acts as a ligand for the cellular uptake of lipoproteins via apoE receptors, members of low-density lipoprotein receptor (LDLR) family, in the CNS. Recently, LDLR family has been shown to have new functions that modulate intracellular signalling and affect neuronal and glial functions, survival and regeneration. However, the pattern of expression of apoE receptors in the CNS has not been fully clarified yet. The LDLR, very low density lipoprotein receptor (VLDLR), LDLR-related protein (LRP), and apolipoprotein E receptor 2 (apoER2) are known to bind to and internalize apoE-containing lipoproteins. Here we summarize the expression of apoE receptors in the CNS and demonstrate additional our original data on cell type specific expression and regulation of those receptors in the CNS, using in situ hybridization and RT-PCR. The cells used in our study were highly enriched cultures of neurons, astrocytes, microglia and oligodendrocytes isolated from rat brain and neuroblastoma cell line, Neuro2a. All of these four types of receptors were shown to be expressed in neurons, astrocytes, microglia and oligodendrocytes, while LDLR and LRP were expressed in Neuro2a cells. We further examined the regulation of the expression of these receptors by altering the cholesterol content of the cells, and found that only the LDLR expression was downregulated following internalization of lipoprotein cholesterol and upregulated by cholesterol deprivation, in neuronal and astroglial cells. These data together with previous studies suggest that LDLR, VLDL, LRP, and apoER2 may be involved in apoE-mediated lipid uptake and/or intracellualr signalling in the cells of the CNS cells, i.e., neurons, astrocytes, microglia, and oligodendrocytes.

Entities:  

Year:  2001        PMID: 23604870      PMCID: PMC3455648          DOI: 10.1007/s11357-001-0001-9

Source DB:  PubMed          Journal:  J Am Aging Assoc        ISSN: 2152-4041


  44 in total

Review 1.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

2.  Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death.

Authors:  M Michikawa; K Yanagisawa
Journal:  J Neurochem       Date:  1999-06       Impact factor: 5.372

3.  The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development.

Authors:  M Narita; G Bu; D M Holtzman; A L Schwartz
Journal:  J Neurochem       Date:  1997-02       Impact factor: 5.372

4.  Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma.

Authors:  J LaMarre; B B Wolf; E L Kittler; P J Quesenberry; S L Gonias
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 5.  The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.

Authors:  U Beffert; M Danik; P Krzywkowski; C Ramassamy; F Berrada; J Poirier
Journal:  Brain Res Brain Res Rev       Date:  1998-07

6.  Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats.

Authors:  J Poirier; A Baccichet; D Dea; S Gauthier
Journal:  Neuroscience       Date:  1993-07       Impact factor: 3.590

7.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis.

Authors:  M Michikawa; K Yanagisawa
Journal:  J Neurosci Res       Date:  1998-10-01       Impact factor: 4.164

9.  Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP).

Authors:  G Zheng; D R Bachinsky; I Stamenkovic; D K Strickland; D Brown; G Andres; R T McCluskey
Journal:  J Histochem Cytochem       Date:  1994-04       Impact factor: 2.479

10.  Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family.

Authors:  H Bujo; M Hermann; M O Kaderli; L Jacobsen; S Sugawara; J Nimpf; T Yamamoto; W J Schneider
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

View more
  11 in total

1.  Neurometabolic roles of ApoE and Ldl-R in mouse brain.

Authors:  Jieun Lee; Joseph Choi; G William Wong; Michael J Wolfgang
Journal:  J Bioenerg Biomembr       Date:  2015-12-21       Impact factor: 2.945

Review 2.  More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration.

Authors:  Courtney Lane-Donovan; Gary T Philips; Joachim Herz
Journal:  Neuron       Date:  2014-08-20       Impact factor: 17.173

3.  High-density lipoprotein facilitates in vivo delivery of α-tocopherol-conjugated short-interfering RNA to the brain.

Authors:  Yoshitaka Uno; Wenying Piao; Kanjiro Miyata; Kazutaka Nishina; Hidehiro Mizusawa; Takanori Yokota
Journal:  Hum Gene Ther       Date:  2011-03-21       Impact factor: 5.695

4.  Absence of selenoprotein P but not selenocysteine lyase results in severe neurological dysfunction.

Authors:  A V Raman; M W Pitts; A Seyedali; A C Hashimoto; L A Seale; F P Bellinger; M J Berry
Journal:  Genes Brain Behav       Date:  2012-05-03       Impact factor: 3.449

Review 5.  ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?

Authors:  Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

6.  A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis.

Authors:  Brian Spencer; Inder Verma; Paula Desplats; Dinorah Morvinski; Ed Rockenstein; Anthony Adame; Eliezer Masliah
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

7.  Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons.

Authors:  Jian-Sheng Gong; Shin-ya Morita; Mariko Kobayashi; Tetsurou Handa; Shinobu C Fujita; Katsuhiko Yanagisawa; Makoto Michikawa
Journal:  Mol Neurodegener       Date:  2007-05-15       Impact factor: 14.195

8.  Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain.

Authors:  Mina Tamaru; Hidetaka Akita; Taichi Nakatani; Kazuaki Kajimoto; Yusuke Sato; Hiroto Hatakeyama; Hideyoshi Harashima
Journal:  Int J Nanomedicine       Date:  2014-09-08

9.  Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer's disease.

Authors:  Anna Binda; Alice Panariti; Andrea Barbuti; Carmen Murano; Roberta Dal Magro; Massimo Masserini; Francesca Re; Ilaria Rivolta
Journal:  Int J Nanomedicine       Date:  2018-07-11

10.  Apolipoprotein E Deficiency Aggravates Neuronal Injury by Enhancing Neuroinflammation via the JNK/c-Jun Pathway in the Early Phase of Experimental Subarachnoid Hemorrhage in Mice.

Authors:  Yue Wu; Jinwei Pang; Jianhua Peng; Fang Cao; Zongduo Guo; Li Jiang; Zhipeng Teng; Zhijian Huang; Chongjie Cheng; Yong Jiang; Xiaochuan Sun
Journal:  Oxid Med Cell Longev       Date:  2019-12-26       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.